10-OXOOCTADECANOIC ACID, 95.0%, 1g

1-(4-Bromo-1H-pyrazol-1-yl)-2-methylpropan-2-ol, 97%, 100mg

3-bromo-5-chloro-4-(prop-2-yn-1-yloxy)benzaldehyde, 95.0%, 1g

4-(4-fluorobenzyl)piperidine hydrochloride, 95.0%, 25g

anti-Keratin K7 mouse monoclonal, Ks7.18, 1 ml

(S,E)-3-(2,6-DICHLORO-4-((4-(3-(1-(HEXYLOXY)ETHYL)-2-METHOXYPHENYL)THIAZOL-2-YL)CARBAMOYL)PHENYL)-2-METHYLACRYLIC ACID, 95%, 100mg

2,2'-(3-Methylthiophene-2,5-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane), 96%, 250mg

(S)-5-(Aminomethyl)-1-(5,7-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)-1H-imidazole-2(3H)-thione hydrochloride, 95.0%, 25mg

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-bromopent-4-enoic acid, 95+%, 1g

4-(4-Bromophenethyl)morpholine, 95.0%, 1g

2-Deoxy-D-Galactose, min. 99%, for biochemistry, 1 g, glass packaging

4-METHYL-2-AZASPIRO[BICYCLO[2.2.2]OCTANE-5,2'-[1,3]DITHIOLAN]-3-ONE, 95.0%, 250mg

1-Benzylpyrrolidine, 97.0%, 25g